Drawing based on the label description. No photo yet.
E LENV 4 mg pill
Pill with imprint E LENV 4 mg is red, capsule, 14 mm and has been identified as Lenvatinib 4 mg. It is used for renal cell carcinoma and thyroid neoplasms. It is supplied by Eisai Inc.
Lenvatinib 4 mg
- Imprint
- E LENV 4 mg
- Strength
- 4 mg
- Used for
- Renal cell carcinoma and thyroid neoplasms
- Color
- Red
- Shape
- Capsule / oblong
- Size
- 14 mm
- Score
- No score line
- Form
- Capsule
- Manufacturer
- Eisai Inc
- Drug class
- Cancer medicine (kinase inhibitor)
- NDC
- 62856-704, 62856-704-05, 62856-704-30, 62856-712, 62856-712-05, 62856-712-30, 62856-714, 62856-714-05, 62856-714-30, 62856-724, 62856-724-05, 62856-724-30, 62856-718, 62856-718-05, 62856-718-30, 62856-708, 62856-708-05, 62856-708-30
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Lenvatinib used for?
Lenvatinib is used for renal cell carcinoma and thyroid neoplasms.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Differentiated Thyroid Cancer
LENVIMA is indicated for the treatment of adult patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC).
Renal Cell Carcinoma
LENVIMA, in combination with pembrolizumab, is indicated for the first-line treatment of adult patients with advanced renal cell carcinoma (RCC).
LENVIMA, in combination with everolimus, is indicated for the treatment of adult patients with advanced RCC following one prior anti-angiogenic therapy.
Hepatocellular Carcinoma
LENVIMA is indicated for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC).
Endometrial Carcinoma
LENVIMA, in combination with pembrolizumab, is indicated for the treatment of patients with advanced endometrial carcinoma (EC) that is mismatch repair proficient (pMMR) or not microsatellite instability-high (MSI-H), as determined by an FDA-approved test, who have disease progression following prior systemic therapy in any setting and are not candidates for curative surgery or radiation.
From the FDA-approved label on DailyMed (published Jun 30, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows E LENV 4 mg. The parts can be split between the two sides, so turn the pill over and check both.
- It is red, capsule, 14 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold under the brand name Lenvima.
Ingredients
Active: Lenvatinib
Inactive: Calcium Carbonate, Hydroxypropyl Cellulose (90000 Wamw), Hydroxypropyl Cellulose, Low Substituted, Mannitol, Cellulose, Microcrystalline, Talc, Ferric Oxide Red, Ferric Oxide Yellow, Hypromelloses, Titanium Dioxide, Ferrosoferric Oxide, Potassium Hydroxide, Propylene Glycol, Shellac
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
G 687
Tacrolimus 5 mg
Red, capsule, 14 mm
Used for eczema
-
B30
Cyclobenzaprine Hydrochloride 30 mg
Blue & red, capsule, 14 mm
Used for muscle stiffness (spasticity) and muscle spasms
-
LA 43
Pregabalin 75 mg
Red & white, capsule, 14 mm
Used for seizures and nerve pain after shingles
Schedule V
-
5MG RDY527
Tacrolimus 5 mg
Red, capsule, 14 mm
Used for eczema
-
R 069
Oxazepam 15 mg
Red, capsule, 14 mm
Used for anxiety and focal seizures
Schedule IV
- Cipla 03050mg Nilotinib 50 mg Red, capsule, 15 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
Other Lenvatinib pills
- E LENV 10 mg Lenvatinib 10 mg Red & yellow, capsule, 14 mm Used for renal cell carcinoma and thyroid neoplasms
- No picture yet DIN 02450321 Lenvatinib Mesylate 10 mg Lenvima, Capsule, sold in Canada Used for renal cell carcinoma and thyroid neoplasms
- No picture yet DIN 02484129 Lenvatinib Mesylate 12 mg Lenvima, Capsule, sold in Canada Used for renal cell carcinoma and thyroid neoplasms
- No picture yet DIN 02450313 Lenvatinib Mesylate 14 mg Lenvima, Capsule, sold in Canada Used for renal cell carcinoma and thyroid neoplasms
- No picture yet DIN 02468239 Lenvatinib Mesylate 18 mg Lenvima, Capsule, sold in Canada Used for renal cell carcinoma and thyroid neoplasms
- No picture yet DIN 02450305 Lenvatinib Mesylate 20 mg Lenvima, Capsule, sold in Canada Used for renal cell carcinoma and thyroid neoplasms
- No picture yet DIN 02450291 Lenvatinib Mesylate 24 mg Lenvima, Capsule, sold in Canada Used for renal cell carcinoma and thyroid neoplasms
- No picture yet DIN 02484056 Lenvatinib Mesylate 4 mg Lenvima, Capsule, sold in Canada Used for renal cell carcinoma and thyroid neoplasms